ロード中...
Compromised functionality of monocyte-derived dendritic cells in multiple myeloma patients may limit their use in cancer immunotherapy
Dendritic cells (DCs) have the potential to elicit long-lasting anti-tumour immune responses. Most of the clinical trials of anti-cancer DC vaccines are based on monocyte-derived DCs (Mo-DCs). However, their outcomes have shown limited promise especially in multiple myeloma (MM) patients. Here, we i...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2018
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5890285/ https://ncbi.nlm.nih.gov/pubmed/29632307 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-018-23943-w |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|